Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans – a practical guide-Reference-Cited by-同舟云学术

Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans – a practical guide

Published:2016-09 Issue:5 Volume:14 Page:657-672
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Burt Tal,John Christy S.,Ruckle Jon L.,Vuong Le T.

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2016.1227786

Reference105 articles.

1. Lessons from 60 years of pharmaceutical innovation

2. How to improve R&D productivity: the pharmaceutical industry's grand challenge

3. Pharmacogenomics in early-phase clinical development

4. Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future;Frontiers in Pharmacology;2024-03-18

2. Evaluation and Application of a PET Tracer in Preclinical and Phase 1 Studies to Determine the Brain Biodistribution of Minzasolmin (UCB0599);Molecular Imaging and Biology;2023-12-18

3. Advances in image-guided drug delivery for antibacterial therapy;Advanced Drug Delivery Reviews;2023-01

4. Phase 0 trials;Translational Sports Medicine;2023

5. Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein;Frontiers in Nuclear Medicine;2022-11-23